Protease inhibitors ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
265	脂肪萎縮症	2

265. 脂肪萎縮症

---

臨床試験数 : 116 /  薬物数 : 170 - (DrugBank : 61) / 標的遺伝子数 : 26 - 標的パスウェイ数 : 97

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00122655 (ClinicalTrials.gov)	January 2001	21/7/2005	Study Evaluating the Impact on Fat Distribution of Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy	A Randomized Prospective Study Evaluating the Impact on Fat Distribution of NRTI-Sparing Regimens in Antiretroviral Experienced Patients With Lipoatrophy ANRS 108 NONUKE Study	HIV Infections;HIV Lipodystrophy Syndrome	Drug: non-nucleoside reverse transcriptase inhibitors;Drug: nucleoside reverse transcriptase inhibitors;Drug: protease inhibitors	French National Agency for Research on AIDS and Viral Hepatitis	NULL	Terminated	18 Years	N/A	Both	100	Phase 4	France
2	NCT00202241 (ClinicalTrials.gov)	September 1999	13/9/2005	The Effects of Anabolic Steroids and Protease Inhibitors on People Living With HIV/AIDS	The Effects of Anabolic Steroids and Protease Inhibitors on Serum Blood Lipids,Muscle Mass, and Total Body Fat in People Living With HIV/AIDS	HIV;AIDS;Lipodystrophy;Hyperlipidemia	Procedure: testosterone injection	Queen's University	Ontario Ministry of Health and Long Term Care	Completed	18 Years	N/A	Both	30	N/A	Canada